Personalizing First Line Therapy For Cll

Summary

Faculty: William Wierda, MD, PhD Faculty: Matthew S. Davids, MD, MMSc This activity focuses on optimizing A talk for Haematology Health Care Professionals on current In this video, Arnon Kater, PhD, of University of Amsterdam, Amsterdam, Netherlands, talks about Moderator Myron Czuczman, MD, leads experts in a discussion about selecting Alessandra Tedeschi, MD, PhD, of the Niguarda Cancer Center, Milan, Italy, gives us her insight into what the future may look  ... At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, John ... Jennifer Woyach, MD, The Ohio State University, Columbus, OH, outlines some of the factors that influence the choice of In this video, Francesca Perutelli, MD, University of Turin, Turin, Italy, provides insight into the findings of the At the 24th Congress of the European Hematology Association (EHA), Wojciech Jurczak from Jagiellonian University, Krakow, PL, ... William G. Wierda, MD, PhD, medical director of the Paula Cramer, MD, University of Cologne, Cologne, Germany, briefly discusses the importance of Parag Jasani, FRCPath, MBBS, MRCP, Royal Free London NHS Foundation Trust, London, UK, explores Kerry Rogers, MD, The Ohio State University, Columbus, OH, discusses how Bruton's tyrosine kinase (BTK) inhibitor use for ...